cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock
YCBD.PRA
YCBD.PRA was delisted on the 5th of May, 2025.
7 hedge funds and large institutions have $216K invested in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
23% more capital invested
Capital invested by funds: $175K → $216K (+$40.7K)
13% less funds holding
Funds holding: 8 → 7 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Marex Group
London,
|
+$23.1K |
| 2 |
CL
CSS LLC
Chicago,
Illinois
|
+$423 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$348 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MG
1
Marex Group
London,
| $64.6K | +$23.1K | +32,732 | +60% |
|
|
CL
2
CSS LLC
Chicago,
Illinois
| $58.5K | +$423 | +600 | +0.8% |
|
|
CD
3
Chapin Davis
Baltimore,
Maryland
| $48K | – | – | – |
|
|
AA
4
Alesco Advisors
Pittsford,
New York
| $32.6K | – | – | – |
|
5
Commonwealth Equity Services
Waltham,
Massachusetts
| $8K | – | – | – |
|
6
Barclays
London,
United Kingdom
| $3.9K | – | – | – |
|
7
Morgan Stanley
New York
| $546 | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$348 | -580 | Closed |
|
YCBD.PRA Hedge Fund Activity: Q4 2024 in Review
7 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) for Q4 2024, worth a combined $216K — up 23% from $175K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of YCBD.PRA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Marex Group, adding an estimated $23.1K. The largest seller was UBS Group, exiting entirely with an estimated $348 sold.
- 7 institutional investors held cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) as of Q4 2024, down from 8 in Q3 2024.
- Funds reported $216K of cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock stock for Q4 2024, up 23% quarter-over-quarter.
- 0 funds opened new cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock positions in Q4 2024 and 1 closed out, a net change of -1 holder.
- The largest cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock buyer in Q4 2024 was Marex Group, an estimated $23.1K added.
- The largest cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock seller in Q4 2024 was UBS Group, an estimated $348 sold.
Based on aggregated 13F filings for Q4 2024.